Trials / Unknown
UnknownNCT00519961
A Prospective Study to Assess the Screening Value of N-terminal Pro-B-type Natriuretic Peptide (NT-proBNP) for the Identification of Patients That Benefit From Additional Cardiac Testing Prior to Vascular Surgery
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,800 (estimated)
- Sponsor
- Hoffmann-La Roche · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to validate the screening potential of NT-proBNP for the identification of patients scheduled for vascular surgery who would benefit from additional pre-operative cardiac testing. All patients will have NT-proBNP concentrations measured pre-operatively. For low-intermediate risk patients only those with abnormal values will receive further cardiac testing; all high risk patients will be referred for additional testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Elecsys®proBNP |
Timeline
- Start date
- 2007-02-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2007-08-23
- Last updated
- 2011-03-16
Locations
2 sites across 2 countries: Ireland, Netherlands
Source: ClinicalTrials.gov record NCT00519961. Inclusion in this directory is not an endorsement.